Weller, K., Staubach, P., Metz, M., Chapman-Rothe, N., Sieder, C., Brautigam, M., & Maurer, M. (2018). Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients with Chronic Idiopathic/Chronic Spontaneous Urticaria: Results from the X-Act Study. SKIN The Journal of Cutaneous Medicine, 2(S1), S53. https://doi.org/10.25251/skin.2.supp.53